13th European Headache Congress

Migraine does not take lives but days from your life. Take them back!

Symposia

May 30th,15:45 - 17:00 

Satellite Symposium 1: Sponsored by Lilly

 

 

Clinical meaningfulness of phase 3 data and approach to treatment guidelines

Chairperson: Prof. Zaza Katsarava, Germany

 AGENDA: 

 

15:45 – 15:55     Welcome and introduction

Prof. Zaza Katsarava, Germany

 

15:55 – 16:20     EHF treatment guidelines: Clinical approach to treating migraine

Prof. Uwe Reuter, Germany

 

16:20 – 16:45     Clinical meaningfulness of phase 3 data: From research to clinic and patient care 

Dr. Rashmi Halker-Singh, United States

 

16:45 – 17:00    Panel discussion, questions and answers, close

All faculty

 

 

 

May 31st, 09:00 - 09:30

Satellite Symposium 2: Sponsored by Cefaly

 

 

e-TNS in the treatment of migraine

Chairs: Prof. D. D. Mitsikostas 
 


09:00 - 09:10     Introduction: rational, technology and parameters

Lecturer: Prof. Stephen Silberstein
 
09:10 - 09:20     Efficacy in migraine prevention

Lecturer: Prof. Jean Schoenen
 
09:20 - 09:30     Efficacy in migraine attack treatment

Lecturer: Prof. D. D. Mitsikostas

 

May 31st, 15:45 - 17:00

Satellite Symposium 3: Sponsored by Teva Pharmaceuticals B.V.

 

 

15:45 - 16:00 Welcome and Introduction

Lecturer: Prof. Dimos D. Mitsikostas


16:00 - 16:15     Epidemiology and Impact of Migraine in Europe

Lecturer: Dr. Patricia Pozo-Rosich


16:15 - 16:30     Innovative Therapies: From Antibody Science to Clinical Utility

Lecturer: Prof. Stephen Silberstein


16:30 - 16:45     Fremanezumab: Results of the Long-term and FOCUS Clinical Trials

Lecturer: Prof. Messoud Ashina


16:45 - 17:00     Q & A

Lecturer: Prof. Dimos D. Mitsikostas

 

May 31st, 17:15 - 18:15
Satellite Symposium 4: Sponsored by Novartis

 

 

New guidelines on CGRP mAbs in migraine prevention – how do they reflect real-world practice?

 Welcome and Introduction

Richard Prof. B. Lipton


Pro:Con debate: The use of CGRP mAbs in the prevention of migraine:
this house believes that robust treatment guidelines can be made based on evidence from randomised placebo controlled trials alone

Prof. Simona Sacco & Prof. Gisela Terwindt


Real-world case study discussion: Contrast between guidelines and clinical practice

Prof. Richard B. Lipton


Panel  Q&A

All faculty


Summary and close

Prof. Richard B. Lipton